HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Molecular markers in breast cancer: practical aspects and morphologic evaluation].

Abstract
The evaluation of molecular markers in breast carcinomas can be routinely assessed by (i) histochemistry for ploidy measurement (Feulgen stain) and for AgNORs counts, and by (ii) immunocytochemistry (Ki67, cathepsin D, pHER-2/neu, EGFR, ER, PR, pS2, p53). Immunocytochemical assays are correlated to biochemical assays and are particularly relevant in small tumors in which only small amount of tissue is available. Immunocytochemical assays provide for data additional to current histological methods, useful for prognostic evaluation and for the selection of node negative patients who may benefit from adjuvant therapy. Nevertheless, immunocytochemical assays can be used for clinical purposes only if they are standardized (frozen sections, image analysis).
AuthorsC Charpin, J F Pellissier
JournalBulletin de l'Academie nationale de medecine (Bull Acad Natl Med) Vol. 178 Issue 3 Pg. 475-87; discussion 487-93 (Mar 1994) ISSN: 0001-4079 [Print] Netherlands
Vernacular TitleMarqueurs moléculaires dans les cancers du sein: aspect pratique et évaluation morphologique.
PMID8076188 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Biomarkers, Tumor
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (analysis)
  • Breast Neoplasms (chemistry, pathology)
  • Evaluation Studies as Topic
  • Female
  • Humans
  • Middle Aged
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: